Back to search

PTHrP(1–36) as a skeletal anabolic agent for the treatment of osteoporosis

Data up to Jan 2025

Published1996
Citations60
References40

Total Citations Per Year

Abstract

References (40)

Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis

1995 • 2,293 citations

Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene.

1994 • 1,138 citations

Estrogen Replacement Therapy and Fractures in Older Women

1995 • 834 citations

Anabolic Actions of Parathyroid Hormone on Bone*

1993 • 721 citations

Skeletal disease in primary hyperparathyroidism

1989 • 616 citations

Defining the roles of parathyroid hormone-related protein in normal physiology

1996 • 576 citations

Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism

1994 • 383 citations

Expression of parathyroid hormone-related peptide and its receptor messenger ribonucleic acids during fetal development of rats.

1995 • 365 citations

Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone

1992 • 364 citations

Nucleolar Localization of Parathyroid Hormone-Related Peptide Enhances Survival of Chondrocytes under Conditions That Promote Apoptotic Cell Death

1995 • 337 citations

The Histomorphometry of Bone in Primary Hyperparathyroidism: Preservation of Cancellous Bone Structure*

1990 • 329 citations

Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism.

1995 • 254 citations

Parathyroid Hormone for the Prevention of Bone Loss Induced by Estrogen Deficiency

1994 • 247 citations

Treatment of Postmenopausal Osteoporosis with Slow-Release Sodium Fluoride: Final Report of a Randomized Controlled Trial

1995 • 246 citations

Parathyroid Hormone-Related Protein as a Prohormone: Posttranslational Processing and Receptor Interactions*

1994 • 214 citations

ANABOLIC EFFECT OF LOW DOSES OF A FRAGMENT OF HUMAN PARATHYROID HORMONE ON THE SKELETON IN POSTMENOPAUSAL OSTEOPOROSIS

1976 • 209 citations

Short-term effects of recombinant human insulin-like growth factor I on bone turnover in normal women.

1993 • 171 citations

Longitudinal measurements of bone density and biochemical indices in untreated primary hyperparathyroidism.

1995 • 165 citations

An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.

1993 • 164 citations

The Parathyroids: Basic and Clinical Concepts

1994 • 162 citations

Mild Asymptomatic Primary Hyperparathyroidism Is Not a Risk Factor for Vertebral Fractures

1988 • 161 citations

Human parathyroid hormone (1–34) and (1–84) increase the mechanical strength and thickness of cortical bone in rats

1993 • 158 citations

Bone structure in postmenopausal hyperparathyroid, osteoporotic, and normal women

1995 • 145 citations

Maintenance of cancellous bone connectivity in primary hyperparathyroidism: Trabecular strut analysis

1992 • 144 citations

Humoral Hypercalcemia of Malignancy

1988 • 125 citations

Parathyroid hormone-related protein. Evidence for secretion of a novel mid-region fragment by three different cell types.

1992 • 122 citations

The Parathyroids: Basic and Clinical Concepts

1994 • 109 citations

Comparison of the Anabolic Effects of Synthetic Parathyroid Hormone-Related Protein (PTHrP) 1–34 and PTH 1–34 on Bone in Rats*

1989 • 105 citations

Bone mineral density in patients with chronic hypoparathyroidism.

1993 • 100 citations

A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss

1995 • 87 citations

Parathyroid hormone (PTH)-related protein(1-36) is equipotent to PTH(1-34) in humans.

1996 • 86 citations

Effects of growth hormone and insulin-like growth factor I in men with idiopathic osteoporosis.

1996 • 83 citations

Attenuation of postmenopausal high turnover bone loss in patients with hypoparathyroidism.

1995 • 77 citations

A comparison of the in vivo biochemical responses to exogenous parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in man.

1992 • 74 citations

Effects of growth hormone and insulin-like growth factor I in men with idiopathic osteoporosis

1996 • 48 citations

The short term effects of tamoxifen on bone turnover in older women.

1995 • 48 citations

Parathyroid hormone-related protein as a prohormone: posttranslational processing and receptor interactions

1994 • 46 citations

Comparison of the pharmacokinetics of parenteral parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in healthy young humans.

1995 • 46 citations

Bone mineral density in patients with chronic hypoparathyroidism

1993 • 38 citations

Synthetic parathyroid hormone-like protein (1?74) is anabolic for bone in vivo

1992 • 35 citations

Cited By (0)

Loading...
PTHrP(1–36) as a skeletal anabolic agent for the treatment of osteoporosis (1996) – Bone | Metascience Observatory Explorer